We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ITCI market cap is 6.35B. The company's latest EPS is USD -1.4428 and P/E is -45.42.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 87.87M | 95.31M | 110.79M | 126.17M | 132.1M |
| Operating Income | -47.41M | -48.39M | -47.18M | -29.71M | -34.1M |
| Net Income | -44.03M | -44.05M | -42.78M | -24.26M | -28.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 61k | 22.81M | 83.8M | 250.31M | 464.37M |
| Operating Income | -154.01M | -231.23M | -285.69M | -263.63M | -159.38M |
| Net Income | -147.72M | -227.01M | -284.13M | -256.26M | -139.67M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 754.78M | 722.16M | 713.6M | 717.66M | 728.3M |
| Total Liabilities | 98.71M | 94.55M | 106.51M | 116.98M | 136.87M |
| Total Equity | 656.07M | 627.61M | 607.09M | 600.68M | 591.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 251.19M | 717.31M | 489.92M | 754.78M | 728.3M |
| Total Liabilities | 56.18M | 60.45M | 72.03M | 98.71M | 136.87M |
| Total Equity | 195.01M | 656.86M | 417.89M | 656.07M | 591.42M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -270.19M | -60.07M | -96.87M | -122.14M | -124.2M |
| Investing | -128.37M | -16.46M | 78.29M | 58.12M | 105.54M |
| Financing | 455.16M | 3.64M | 12.23M | 14.81M | 17.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -127.98M | -230.07M | -259.54M | -270.19M | -124.2M |
| Investing | 177.44M | -480.3M | 280.34M | -128.37M | 105.54M |
| Financing | 3.24M | 664.18M | 11.52M | 455.16M | 17.81M |
| Market Cap | 6.35B |
| Price to Earnings Ratio | -45.42 |
| Price to Sales Ratio | 13.66 |
| Price to Cash Ratio | 42.93 |
| Price to Book Ratio | 10.73 |
| Dividend Yield | - |
| Shares Outstanding | 96.81M |
| Average Volume (1 week) | 1M |
| Average Volume (1 Month) | 1.53M |
| 52 Week Change | 3.10% |
| 52 Week High | 84.89 |
| 52 Week Low | 45.50 |
| Spread (Intraday) | 0.46 (0.7%) |
| Company Name | Intra Cellular Therapies Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.intracellulartherapies.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
